353
A RETROSPECTIVE EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF RITUXIMAB BIOSIMILAR (RTXM83) IN BRAZILIAN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
Lido
2312
Vezesque se leu este artigo
1145
Total PDF
1167
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 17 | 8 | 25 |
| 2025 5 | 57 | 16 | 73 |
| 2025 4 | 32 | 13 | 45 |
| 2025 3 | 46 | 14 | 60 |
| 2025 2 | 34 | 21 | 55 |
| 2025 1 | 43 | 21 | 64 |
| 2024 12 | 44 | 12 | 56 |
| 2024 11 | 28 | 14 | 42 |
| 2024 10 | 17 | 17 | 34 |
| 2024 9 | 24 | 24 | 48 |
| 2024 8 | 28 | 26 | 54 |
| 2024 7 | 18 | 20 | 38 |
| 2024 6 | 18 | 21 | 39 |
| 2024 5 | 22 | 22 | 44 |
| 2024 4 | 26 | 17 | 43 |
| 2024 3 | 19 | 15 | 34 |
| 2024 2 | 18 | 21 | 39 |
| 2024 1 | 14 | 18 | 32 |
| 2023 12 | 16 | 14 | 30 |
| 2023 11 | 29 | 26 | 55 |
| 2023 10 | 18 | 23 | 41 |
| 2023 9 | 13 | 23 | 36 |
| 2023 8 | 19 | 15 | 34 |
| 2023 7 | 19 | 14 | 33 |
| 2023 6 | 21 | 17 | 38 |
| 2023 5 | 24 | 13 | 37 |
| 2023 4 | 9 | 2 | 11 |
| 2023 3 | 16 | 13 | 29 |
| 2023 2 | 12 | 9 | 21 |
| 2023 1 | 17 | 14 | 31 |
| 2022 12 | 21 | 20 | 41 |
| 2022 11 | 20 | 24 | 44 |
| 2022 10 | 17 | 20 | 37 |
| 2022 9 | 21 | 23 | 44 |
| 2022 8 | 19 | 22 | 41 |
| 2022 7 | 18 | 28 | 46 |
| 2022 6 | 13 | 19 | 32 |
| 2022 5 | 9 | 17 | 26 |
| 2022 4 | 14 | 28 | 42 |
| 2022 3 | 9 | 24 | 33 |
| 2022 2 | 17 | 29 | 46 |
| 2021 1 | 11 | 21 | 32 |
| 2021 12 | 9 | 22 | 31 |
| 2021 11 | 14 | 24 | 38 |
| 2021 10 | 25 | 32 | 57 |
| 2021 9 | 15 | 25 | 40 |
| 2021 8 | 28 | 45 | 73 |
| 2021 7 | 25 | 39 | 64 |
| 2021 6 | 15 | 31 | 46 |
| 2021 5 | 12 | 29 | 41 |
| 2021 4 | 33 | 29 | 62 |
| 2021 3 | 25 | 30 | 55 |
| 2021 2 | 14 | 15 | 29 |
| 2020 1 | 13 | 17 | 30 |
| 2020 12 | 15 | 18 | 33 |
| 2020 11 | 17 | 11 | 28 |
Mostrar tudo
